Novartis launch renewed attack on India’s right to produce affordable medicines
Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
The hearing, in the Indian Supreme Court, comes six years after Novartis first lost its battle to stop India producing copies of anti-cancer medicine Glivec (or Gleevec in the USA), which cost as much as ten times less than the original. Now Novartis are trying to find a loophole that would delay the ability of Indian drug companies to produce cheaper medicines, which supply most of the developing world.
The complicated legal wrangle over how India implements specific patent rules could set a groundbreaking legal precedent. If Novartis wins the case, similar claims for other medicines pending in court could go in favor of drug companies rather than the people whose lives depend on affordable generic drugs.
A source of life saving medication for millions
Oxfam Policy Advisor, Rohit Malpani, said: “Despite the fact Novartis has lost before, the company seems hell bent on pursuing this case and is determined to win a precedent, even though it could have a devastating impact on millions of people in developing countries.”
Generic medicines produced in India are among the cheapest in the world, and are the main source of life saving medication for millions. 90 per cent of medicines used to treat HIV/AIDS are currently made in India, but Novartis is putting India’s future as the ‘pharmacy of the developing world’ at stake. If the case is successful the result would mean delays in competition for all medicines produced, which would push prices up and have a significant impact on public health.
Malpani said: “This legal battle is a massive threat to those suffering from cancer, HIV and AIDS, diabetes and other diseases who are too poor to pay for medication.
Patients’ rights first
“India is setting a brave example for other developing countries, by standing firm under pressure from multinational drugs companies by putting patients’ rights first. The case must rule in favor of people not profits.”
Oxfam was part of a global campaign in 2006 calling on Novartis to put people before profits, which was backed by half a million people.
Blog: Robbing the poor to pay the rich – Novartis’ Christmas gift to itself! (Dec. 2008)
Video: Free medicines in Rajasthan, India (Feb. 2012)
Stop AIDS Campaign animation explains the 'patent pool'
Notes to Editors
In 2006, Novartis launched a legal battle challenging India's adoption of strict standards used to regulate patents on medicines. They argued that Section 3(d) of the recently amended Patents Act was ‘unconstitutional and violated international standards’ and wanted a 20-year patent monopoly on Glivec. The company is now challenging the established interpretation of Section (d) which requires a minor variation to previously invented medicines not be granted unless it significantly enhances the efficiency of the medicine in treating human illness or disease.
For more information, or to arrange an interview with an Oxfam spokesperson, please contact:
Sarah Dransfield, Oxfam press Officer: +44 (0)1865 472269, +44 (0)7767 085666, firstname.lastname@example.org, twitter: @SarahOxfam
Photo of the wk: Young Ahmed holds the keys to 1 of 48 new wash blocks, Zaatari camp #Jordan http://t.co/qOs5BOPh63 #Syria #refugees19 hours 55 min ago
1000s homeless again, searching for safety as violence erupts again in eastern #DRC http://t.co/C3cLwXNit3 $1bn WorldBank aid pledge21 hours 16 min ago
UN Disaster Risk Reduction Conference: Good, but needs to go further http://t.co/Hm54O1EsXT #GPDRR13 #drr @UNDP @unisdr @odi_development22 hours 20 min ago
European #taxhavens are 2/3 of the $150 billion tax loss problem http://t.co/jax7i3jVsd #G8 #taxdodging #transparency1 day 52 sec ago
Thx @Food_Tank! Proud 2b in 40 Orgs Shaking Up the Food System list @IFADnews @millenniuminst @OneAcreFund @ONECampaign @rocunited @FAOnews1 day 2 hours ago
RT @oxfamgb: Good news of £30m extra funding from @DFID_UK for #Syria. Still need more aid from others & big push for a peace. http://t.co/…1 day 2 hours ago
US pushes Europe to amend arms #embargo on Syrian rebels http://t.co/B8KYe8VNQn #SyriaCrisis @StateDept @WilliamJHague @eu_eeas @OxfamEU1 day 2 hours ago
+80,000 ppl have been killed & several million displaced since the #SyriaCrisis began; #EU must extend arms embargo http://t.co/JlpzH9egf71 day 3 hours ago
RT @Katie_Nguyen1: Another arresting headline from @katymigiro 'Chips for sex: Oxfam explores the lives of #Kenya’s hungry millions' http:…1 day 3 hours ago
RT @liviafirth: 1 empowered woman can spark a positive change for her whole community @Oxfam @thecircle_oxfam #SparksthatFly @eco_age1 day 3 hours ago
RT @Karl_Schembri: #Syria children nxt to newly installed water tap outside 1 of 48 new wash blocks by @Oxfam in #Zaatari Camp, #Jordan htt…1 day 4 hours ago
The #ArmsTreaty can create a safer future for millions, but first it needs signatures. Urge the US to sign! http://t.co/4YUsIawus71 day 6 hours ago
#EU foreign ministers must bite the bullet & extend the arms #embargo on #Syria http://t.co/rL80yARiSt #SyriaCrisis #ArmsTreaty1 day 12 hours ago
RT @OxfamIreland: Ireland pledges €2.5 million in aid to Mali to contribute to reconstruction http://t.co/wvUzsRsHoD via @IrishTimes #Mal…1 day 20 hours ago
As @UN Disaster Risk Reduction Conference ends, worth checking #GPDRR13 for great tweets from @unisdr @UNOCHA @Federation et al1 day 20 hours ago